SWM
Stockman Wealth Management Portfolio holdings
AUM
$736M
This Quarter Return
-11.16%
1 Year Return
+11.38%
3 Year Return
+50.59%
5 Year Return
+95.54%
10 Year Return
+167.07%
AUM
$209M
AUM Growth
+$209M
(-9.8%)
Cap. Flow
+$2.75M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
27.57%
Holding
156
New
4
Increased
64
Reduced
46
Closed
6
Top Buys
| 1 |
Phillips 66
PSX
|
$2.5M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
$815K |
| 3 |
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
$679K |
| 4 |
DuPont de Nemours
DD
|
$566K |
| 5 |
Bank of New York Mellon
BK
|
$520K |
Top Sells
| 1 |
CSR
Centerspace
CSR
|
$1.47M |
| 2 |
Nuveen Municipal Value Fund
NUV
|
$713K |
| 3 |
Cisco
CSCO
|
$705K |
| 4 |
Pfizer
PFE
|
$527K |
| 5 |
Oracle
ORCL
|
$465K |
Sector Composition
| 1 | Healthcare | 17.25% |
| 2 | Technology | 13.58% |
| 3 | Financials | 10.89% |
| 4 | Energy | 10.37% |
| 5 | Consumer Staples | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$210B
| $7.38M | 3.53% | 96,627 -636 | -0.7% | -$48.6K |
|
2
Procter & Gamble
PG
$368B
| $6.25M | 2.99% | 68,028 -1,400 | -2% | -$129K |
|
3
Microsoft
MSFT
$3.77T
| $6.24M | 2.98% | 61,450 -407 | -0.7% | -$41.3K |
|
4
Berkshire Hathaway Class B
BRK.B
$1.09T
| $5.8M | 2.77% | 28,401 -41 | -0.1% | -$8.37K |
|
|
5
iShares Floating Rate Bond ETF
FLOT
$9.15B
| $5.76M | 2.75% | 114,465 +16,185 | +16% | +$815K |
|
|
6
Pfizer
PFE
$141B
| $5.64M | 2.7% | 129,269 -12,073 | -9% | -$527K |
|
7
Intel
INTC
$107B
| $5.56M | 2.66% | 118,561 -9,242 | -7% | -$434K |
|
8
Exxon Mobil
XOM
$487B
| $5.23M | 2.5% | 76,758 +471 | +0.6% | +$32.1K |
|
9
AT&T
T
$209B
| $5.14M | 2.45% | 180,042 +3,731 | +2% | +$106K |
|
10
RTX Corp
RTX
$212B
| $4.7M | 2.24% | 44,105 +196 | +0.4% | +$20.9K |
|
|
11
Cisco
CSCO
$274B
| $4.59M | 2.19% | 105,981 -16,269 | -13% | -$705K |
|
12
Apple
AAPL
$3.45T
| $4.49M | 2.15% | 28,470 +545 | +2% | +$86K |
|
13
Chevron
CVX
$324B
| $4.3M | 2.05% | 39,538 +2,308 | +6% | +$251K |
|
14
AstraZeneca
AZN
$248B
| $4.3M | 2.05% | 113,132 -1,487 | -1% | -$56.5K |
|
15
AbbVie
ABBV
$372B
| $4.29M | 2.05% | 46,564 +1,586 | +4% | +$146K |
|
16
JPMorgan Chase
JPM
$829B
| $4.17M | 1.99% | 42,732 +1,131 | +3% | +$110K |
|
|
17
Bank of New York Mellon
BK
$74.5B
| $4.15M | 1.98% | 88,165 +11,050 | +14% | +$520K |
|
18
American Express
AXP
$231B
| $3.84M | 1.83% | 40,278 -901 | -2% | -$85.9K |
|
19
Occidental Petroleum
OXY
$46.9B
| $3.79M | 1.81% | 61,749 +3,230 | +6% | +$198K |
|
|
20
Oracle
ORCL
$635B
| $3.78M | 1.81% | 83,722 -10,289 | -11% | -$465K |
|
|
21
DuPont de Nemours
DD
$32.2B
| $3.5M | 1.67% | 65,469 +10,589 | +19% | +$566K |
|
|
WBA
22
DELISTED
Walgreens Boots Alliance
WBA
| $3.41M | 1.63% | 49,897 -805 | -2% | -$55K |
|
23
Gilead Sciences
GILD
$140B
| $3.34M | 1.6% | 53,406 +1,566 | +3% | +$98K |
|
24
GSK
GSK
$79.9B
| $3.22M | 1.54% | 84,382 +898 | +1% | +$34.3K |
|
25
Lowe's Companies
LOW
$145B
| $3.17M | 1.52% | 34,332 +45 | +0.1% | +$4.16K |
|